http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-101726-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c82fea9cd3dc48540ebd26d3b952479
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
filingDate 1987-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08000e40ba9d6dacd3610775255c4785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d6a60bdfe16bdcc83d40fc4e107bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c52024209e33f3f2bdaf3909d5b164f0
publicationDate 1992-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MY-101726-A
titleOfInvention (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
abstract (S)-ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETAMIDE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. IT CAN BE PREPARED EITHER BY REACTING (S)-ALPHA-ETHYL-2-OXO-1-PYRROLIDINEACETIC ACID SUCCESSIVELY WITH AN ALKYL HALOFORMATE AND WITH AMMONIA, OR, BY CYCLIZING AN (S)-2-AMONI-BUTANAMIDE OF THE FORMULA X-CH2CH2-Y-NHCH(C2H5)CONH2 WHEREIN Y IS A -CH2- RADICAL WHEN X REPRESENTS A ZOOC- RADICAL AND Y IS A -CO- RADICAL WHEN X REPRESENTS HALCH2- RADICAL, Z BEING A C1-C4 ALKYL RADICAL AND HAL A HALOGEN ATOM. THIS LAEVOROTARY ENANTIOMER HAS BEEN FOUND TO HAVE SIGNIFICANTLY HIGHER PROTECTIVE ACTIVITY AGAINST HYPOXIA AND ISCHEMIA THAN THE CORRESPONDING RACEMATE.
priorityDate 1984-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11607993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426181037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506214

Total number of triples: 33.